1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > BioMark Technologies Inc. - Product Pipeline Analysis, 2015 Update

Summary

BioMark Technologies Inc. (BioMark Technologies) is a biotechnology service providing company which develops and provides a range of portable screening tools for the treatment of cancers. The company manufactures and distributes diagnostic systems for the detection and diagnosis of cancer. It offers its technology for diagnosis, response to treatment, prognosis and drug therapy. BioMark Technologies partners with various other healthcare providers, universities and research and development organizations. The company has its presence in China and Canada. BioMark Technologies is headquartered in Richmond, British Columbia, Canada.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company BioMark Technologies Inc.
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Table Of Contents

BioMark Technologies Inc. - Product Pipeline Analysis, 2015 Update
Table of Contents


Table of Contents 2

List of Tables
4

List of Figures
4
BioMark Technologies Inc. Company Snapshot 5
BioMark Technologies Inc. Company Overview 5
Key Information 6
BioMark Technologies Inc. Pipeline Products and Clinical Trials Overview 6
BioMark Technologies Inc. - Pipeline Analysis Overview 9
Key Facts 9
BioMark Technologies Inc. - Major Products and Services 10
BioMark Technologies Inc. Pipeline Products by Development Stage 11
BioMark Technologies Inc. Pipeline Products Overview 13
Biomarker Assay - Ovarian Cancer 13
Biomarker Assay - Ovarian Cancer Product Overview 13
Biomarker Assay - Pancreatic Cancer 14
Biomarker Assay - Pancreatic Cancer Product Overview 14
Biomarker Assay - Bladder Cancer 15
Biomarker Assay - Bladder Cancer Product Overview 15
Biomarker Assay - Breast Cancer 16
Biomarker Assay - Breast Cancer Product Overview 16
Biomarker Assay - Cervical Cancer 17
Biomarker Assay - Cervical Cancer Product Overview 17
Biomarker Assay - Colorectal Cancer 18
Biomarker Assay - Colorectal Cancer Product Overview 18
Biomarker Assay - Esophagus Cancer 19
Biomarker Assay - Esophagus Cancer Product Overview 19
Biomarker Assay - Hepatocellular Cancer 20
Biomarker Assay - Hepatocellular Cancer Product Overview 20
Biomarker Assay - Kidney Cancer 21
Biomarker Assay - Kidney Cancer Product Overview 21
Biomarker Assay - Lung Cancer 22
Biomarker Assay - Lung Cancer Product Overview 22
Biomarker Assay - Mesothelium Cancer 23
Biomarker Assay - Mesothelium Cancer Product Overview 23
Biomarker Assay - Prostate Cancer 24
Biomarker Assay - Prostate Cancer Product Overview 24
ELISA Kit - Polyclonal Antibody 25
ELISA Kit - Polyclonal Antibody Product Overview 25
POC Device - Monoclonal Antibodies 26
POC Device - Monoclonal Antibodies Product Overview 26
SSAT Diagnostic Assay - Cancer 27
SSAT Diagnostic Assay - Cancer Product Overview 27
BioMark Technologies Inc. - Key Competitors 28
BioMark Technologies Inc. - Key Employees 29
BioMark Technologies Inc. - Locations And Subsidiaries 30
Head Office 30
Other Locations and Subsidiaries 30
Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31


List of Tables

BioMark Technologies Inc., Key Facts 6
BioMark Technologies Inc. Pipeline Products and Clinical Trials Overview 6
BioMark Technologies Inc. Pipeline Products by Equipment Type 7
BioMark Technologies Inc. Pipeline Products by Indication 8
BioMark Technologies Inc., Key Facts 9
BioMark Technologies Inc., Major Products and Services 10
BioMark Technologies Inc. Number of Pipeline Products by Development Stage 11
BioMark Technologies Inc. Pipeline Products Summary by Development Stage 12
Biomarker Assay - Ovarian Cancer - Product Status 13
Biomarker Assay - Ovarian Cancer - Product Description 13
Biomarker Assay - Pancreatic Cancer - Product Status 14
Biomarker Assay - Pancreatic Cancer - Product Description 14
Biomarker Assay - Bladder Cancer - Product Status 15
Biomarker Assay - Bladder Cancer - Product Description 15
Biomarker Assay - Breast Cancer - Product Status 16
Biomarker Assay - Breast Cancer - Product Description 16
Biomarker Assay - Cervical Cancer - Product Status 17
Biomarker Assay - Cervical Cancer - Product Description 17
Biomarker Assay - Colorectal Cancer - Product Status 18
Biomarker Assay - Colorectal Cancer - Product Description 18
Biomarker Assay - Esophagus Cancer - Product Status 19
Biomarker Assay - Esophagus Cancer - Product Description 19
Biomarker Assay - Hepatocellular Cancer - Product Status 20
Biomarker Assay - Hepatocellular Cancer - Product Description 20
Biomarker Assay - Kidney Cancer - Product Status 21
Biomarker Assay - Kidney Cancer - Product Description 21
Biomarker Assay - Lung Cancer - Product Status 22
Biomarker Assay - Lung Cancer - Product Description 22
Biomarker Assay - Mesothelium Cancer - Product Status 23
Biomarker Assay - Mesothelium Cancer - Product Description 23
Biomarker Assay - Prostate Cancer - Product Status 24
Biomarker Assay - Prostate Cancer - Product Description 24
ELISA Kit - Polyclonal Antibody - Product Status 25
ELISA Kit - Polyclonal Antibody - Product Description 25
POC Device - Monoclonal Antibodies - Product Status 26
POC Device - Monoclonal Antibodies - Product Description 26
SSAT Diagnostic Assay - Cancer - Product Status 27
SSAT Diagnostic Assay - Cancer - Product Description 27
BioMark Technologies Inc., Key Employees 29
BioMark Technologies Inc., Other Locations 30


List of Figures

BioMark Technologies Inc. Pipeline Products by Equipment Type 7
BioMark Technologies Inc. Pipeline Products by Development Stage 11

Companies Mentioned

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
Tyrosine Protein Kinase Mer (Proto Oncogene c Mer or Receptor Tyrosine Kinase MerTK or MERTK or EC 2.7.10.1) - Pipeline Review, H2 2016

Tyrosine Protein Kinase Mer (Proto Oncogene c Mer or Receptor Tyrosine Kinase MerTK or MERTK or EC 2.7.10.1) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • August 2016
  • by Global Markets Direct

Tyrosine Protein Kinase Mer (Proto Oncogene c Mer or Receptor Tyrosine Kinase MerTK or MERTK or EC 2.7.10.1) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Tyrosine Protein Kinase Me ...

Histone Lysine N Methyltransferase EZH2 (ENX 1 or Enhancer Of Zeste Homolog 2 or Lysine N Methyltransferase 6 or EZH2 or EC 2.1.1.43) - Pipeline Review, H2 2016

Histone Lysine N Methyltransferase EZH2 (ENX 1 or Enhancer Of Zeste Homolog 2 or Lysine N Methyltransferase 6 or EZH2 or EC 2.1.1.43) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • August 2016
  • by Global Markets Direct

Histone Lysine N Methyltransferase EZH2 (ENX 1 or Enhancer Of Zeste Homolog 2 or Lysine N Methyltransferase 6 or EZH2 or EC 2.1.1.43) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Histone ...

Tyrosine Protein Kinase ITK/TSK (Interleukin 2 Inducible T Cell Kinase or T Cell Specific Kinase or Kinase EMT or Tyrosine Protein Kinase Lyk or ITK or EC 2.7.10.2) - Pipeline Review, H2 2016

Tyrosine Protein Kinase ITK/TSK (Interleukin 2 Inducible T Cell Kinase or T Cell Specific Kinase or Kinase EMT or Tyrosine Protein Kinase Lyk or ITK or EC 2.7.10.2) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • August 2016
  • by Global Markets Direct

Tyrosine Protein Kinase ITK/TSK (Interleukin 2 Inducible T Cell Kinase or T Cell Specific Kinase or Kinase EMT or Tyrosine Protein Kinase Lyk or ITK or EC 2.7.10.2) - Pipeline Review, H2 2016 Summary Global ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.